Samsung Partners With Massachusetts General Hospital to Tackle GLP-1 Muscle Loss via Galaxy Watch
Samsung and MGH are testing if Galaxy Watch biometric data can prevent lean muscle mass loss in patients using GLP-1 medications like Ozempic.
Samsung and MGH are testing if Galaxy Watch biometric data can prevent lean muscle mass loss in patients using GLP-1 medications like Ozempic.
Originally designed for leukemia, CAR T cell therapy is now entering clinical trials for MS, lupus, and stiff person syndrome, promising a systemic 'reset' of the immune system.